Vicarious Surgical Inc Financials
This page shows Vicarious Surgical Inc (RBOT) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 6 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Vicarious Surgical’s reported improvement is driven by expense contraction while operating cash needs remain closely tied to ongoing losses.
In FY2025, net loss was-$50.2M versus operating cash flow of-$45.1M . FCF of-$45.2M nearly matched operating cash flow, a pattern also visible in FY2024, indicating that reported losses are translating into cash consumption rather than being primarily noncash accounting charges.
Because the supplied periods contain no revenue figure, the operating-loss improvement from
Capital spending fell to
Financial Health Signals
Vicarious Surgical Inc does not currently provide enough eligible data for a peer-relative financial health score, so none is published. The signals and metrics below are current.
Vicarious Surgical Inc reported a net loss of $50.2M while operations used $45.1M of cash. With neither figure positive, the ratio between the two carries no quality signal.
Key Financial Metrics
Earnings & Revenue
Vicarious Surgical Inc's EBITDA was -$48.6M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 24.6% from the prior year.
Vicarious Surgical Inc reported -$50.2M in net income in fiscal year 2025. This represents an increase of 20.6% from the prior year.
Not reported for fiscal year 2025.
Not reported for fiscal year 2025.
Cash & Balance Sheet
Vicarious Surgical Inc recorded an outflow of $45.2M in free cash flow in fiscal year 2025, representing a cash shortfall after capex. This represents an increase of 9.8% from the prior year.
Vicarious Surgical Inc held $9.8M in cash as of fiscal year 2025; long-term debt is not reported for that period.
Not reported for fiscal year 2025.
Margins & Returns
None of these metrics is reported for fiscal year 2025.
Capital Allocation
Vicarious Surgical Inc invested $33.6M in research and development in fiscal year 2025. This represents a decrease of 16.3% from the prior year.
Vicarious Surgical Inc invested $132K in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents a decrease of 26.7% from the prior year.
Not reported for fiscal year 2025.
RBOT Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.
| Metric | Q2'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 |
|---|---|---|---|---|---|---|---|---|
| R&D Expenses | $5.0M | N/A | $8.0M-11.7% | $9.1M | N/A | N/A | $10.8M-1.1% | $10.9M |
| SG&A Expenses | $2.1M | N/A | $3.2M-23.3% | $4.1M | N/A | N/A | $5.7M+2.8% | $5.6M |
| Operating Income | -$7.5M | N/A | -$11.5M+14.9% | -$13.5M | N/A | N/A | -$17.8M-0.2% | -$17.7M |
| Net Income | -$7.3M | N/A | -$11.1M+16.3% | -$13.2M | N/A | N/A | -$17.1M-12.4% | -$15.2M |
| EPS (Diluted) | -$1.03 | N/A | N/A | N/A | N/A | N/A | N/A | -$2.59 |
Not reported in any period shown, so not listed: Revenue, Cost of Revenue, Gross Profit, Interest Expense, Income Tax.
RBOT Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.
| Metric | Q2'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $12.6M | N/A | $29.3M-28.2% | $40.9M-25.7% | $55.1M-18.7% | $67.7M-16.0% | $80.6M-13.6% | $93.3M |
| Current Assets | $5.2M | N/A | $15.1M-42.2% | $26.1M-34.3% | $39.7M-23.3% | $51.7M-19.2% | $64.0M-15.7% | $75.9M |
| Cash & Equivalents | $1.4M-85.6% | $9.8M+209.5% | $3.2M-19.1% | $3.9M+50.4% | $2.6M-73.3% | $9.7M+37.7% | $7.1M-65.1% | $20.3M |
| Total Liabilities | $9.0M | N/A | $15.3M-14.4% | $17.8M-15.0% | $21.0M-0.2% | $21.0M-7.5% | $22.7M+5.8% | $21.5M |
| Current Liabilities | $3.3M | N/A | $3.2M-37.7% | $5.1M-35.1% | $7.9M+2.5% | $7.7M-10.9% | $8.6M+19.8% | $7.2M |
| Total Equity | $3.6M | N/A | $14.1M-38.9% | $23.1M-32.3% | $34.1M-27.0% | $46.7M-19.3% | $57.9M-19.5% | $71.9M |
| Retained Earnings | -$253.4M | N/A | -$235.6M-4.9% | -$224.5M-6.3% | -$211.3M-7.9% | -$195.9M-7.7% | -$182.0M-10.4% | -$164.9M |
Not reported in any period shown, so not listed: Inventory, Accounts Receivable, Goodwill, Long-Term Debt.
RBOT Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.
| Metric | Q2'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -$6.3M+32.1% | -$9.3M+11.0% | -$10.5M | N/A | N/A | -$11.8M+7.1% | -$12.7M-15.1% | -$11.0M |
| Capital Expenditures | $9K | N/A | N/A | N/A | N/A | N/A | N/A | $6K |
| Free Cash Flow | -$6.3M | N/A | N/A | N/A | N/A | N/A | N/A | -$11.0M |
| Investing Cash Flow | $5.1M+67.4% | $3.0M-68.8% | $9.7M | N/A | N/A | $14.4M+3037.0% | -$492K+92.9% | -$7.0M |
| Financing Cash Flow | -$154K-102.7% | $5.7M+21800.0% | $26K | N/A | N/A | $6K | $0 | $0 |
Not reported in any period shown, so not listed: Dividends Paid, Share Buybacks.
RBOT Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples.
| Metric | Q2'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 |
|---|---|---|---|---|---|---|---|---|
| Return on Equity | -205.3% | N/A | -78.5%-21.2pp | -57.3% | N/A | N/A | -29.5%-8.4pp | -21.2% |
| Return on Assets | -58.2% | N/A | -37.7%-5.4pp | -32.3% | N/A | N/A | -21.2%-4.9pp | -16.3% |
| Current Ratio | 1.54 | N/A | 4.75-0.4x | 5.11+0.1x | 5.05-1.7x | 6.74-0.7x | 7.44-3.1x | 10.57 |
| Debt-to-Equity | 2.53 | N/A | 1.08+0.3x | 0.77+0.2x | 0.62+0.2x | 0.45+0.1x | 0.39+0.1x | 0.30 |
Not reported in any period shown, so not listed: Gross Margin, Operating Margin, Net Margin, FCF Margin.
Similar Companies
Where Vicarious Surgical Inc Ranks
Frequently Asked Questions
Is Vicarious Surgical Inc profitable?
No, Vicarious Surgical Inc (RBOT) reported a net income of -$50.2M in fiscal year 2025.
What is Vicarious Surgical Inc's EBITDA?
Vicarious Surgical Inc (RBOT) had EBITDA of -$48.6M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
What is Vicarious Surgical Inc's free cash flow?
Vicarious Surgical Inc (RBOT) recorded an outflow of $45.2M in free cash flow during fiscal year 2025. This represents a 9.8% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is Vicarious Surgical Inc's operating cash flow?
Vicarious Surgical Inc (RBOT) recorded an outflow of $45.1M in operating cash flow during fiscal year 2025, representing cash used by core business activities.
What are Vicarious Surgical Inc's capital expenditures?
Vicarious Surgical Inc (RBOT) invested $132K in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
How much does Vicarious Surgical Inc spend on research and development?
Vicarious Surgical Inc (RBOT) invested $33.6M in research and development during fiscal year 2025.
How does Vicarious Surgical Inc's liquidity compare with its operating cash outflow?
At the end of fiscal year 2025, Vicarious Surgical Inc (RBOT) held $9.8M in cash, cash equivalents and investments, and reported an operating cash outflow of $45.1M over that year. Dividing the one by the other, the reported balance equals about 3 months of the outflow reported that year. This is arithmetic over figures already filed, not a projection: it assumes nothing about future spending, financing or operations.
Are Vicarious Surgical Inc's earnings high quality?
Vicarious Surgical Inc (RBOT) reported a net loss of $50.2M while operations used $45.1M of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.